{"name":"Epicrispr Biotechnologies, Inc.","slug":"epicrispr-biotechnologies-inc","ticker":"","exchange":"","domain":"epicrisprbiotechnologies.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQUGR2LTZ6OUtkelJNT2RLSS12bGxFd04wdnQ4UU1fNWtHT1ozYzNoaDY0U0c1T3dZOGNKYktkVVdaaE9scmNWdXJsRnY2ZUMtZ0ROQ1FPZ050M2JMUThILXdmVUVZbjNsSkpPTWJYaU80R254S1BtZTRtZEpxYTFuYg?oc=5","date":"2026-03-24","type":"pipeline","source":"Fast Company","summary":"The most innovative biotech companies of 2026 - Fast Company","headline":"The most innovative biotech companies of 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOQkxmbk12TjRSRXhEVnFZTGotcy1sUlZsYXdPSTNBeV9BTk40QnJraDBzeHppNGpuR0JLVmk3TV82a0drdXhTdUpGOTgzMk5DbVdlclZYMTQzSzlfelE1eTdwYXpGVXBNMzV6eW05ZjBPLTFTMHF5TUNscEVlTkhqWQ?oc=5","date":"2025-12-19","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxOSGZaM19GR05Hdy1yY3lTS1ZGMDY2UThXSWx2LVVhUWh0N2xYTnYwdXNFU0wxRHo3alQ1T1hDZWdYZWZsbVliSXM1YXNzekprTEZPcnF3U3lYUS1aYzYwdlZ0SEprLWlFWE5vb3poZVo0ZWJnOW4zWmJHcWZYYmRyX05KdS05S0liUjJ6dGcyenBrNktkdWtWZS1BbUd1VGVNb21CYWpPWk9qc0JScHVrUzNPN1hZbVlzUUpycmxyWWtoWHc1ZDZCSU1mN1k3RExjM3BQdUthOFNiQTRxYUVVZzBLSUY1S2toR05uSjQ1U0NNVGNxNXM5WkN1cldVTWZ2dDJ3S2lOYWs3bzJHNU9lVDBWYXBzU0tF?oc=5","date":"2025-10-02","type":"trial","source":"GlobeNewswire","summary":"CRISPR Therapies Clinical Trial Pipeline Shows Potential - GlobeNewswire","headline":"CRISPR Therapies Clinical Trial Pipeline Shows Potential","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTFBqcWpFZ21FVTRWbGNncmNZTzVCWjYyTjNsMEttN2Y5MDA2YkZWbWI3WmEyMDN5djYyTjd5aTlxQ0dtaWFNd0l4RDlkQ3A1QmY4Q0dEQTFneEp4aXViRDZuMUtFOFd6Z2I1?oc=5","date":"2025-04-02","type":"pipeline","source":"The Pharma Letter","summary":"Epicrispr Biotechnologies - The Pharma Letter","headline":"Epicrispr Biotechnologies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOYVhCdm9hSUU0OVFNOFpaaXJGMWR4NU5zNG9kNmVnMDloZlhtcGp4SnJ0WUdwUTF0TWhhZXBOMWstYkx3UzFrZkRJRE1xNlQwSklwT19QMUpqTldTaUd0WU8xZThoNXNoanJabEg4clBoS0ItYlpKcm52MlYtdlVFREFwNjFUaEFwMEg2ckMtR1d1M1c2OWs2SkFtZHBNcDZVNDdzQktZQS1YQQ?oc=5","date":"2025-04-01","type":"pipeline","source":"MedCity News","summary":"An AI Biotech Hauls In $600M, Plus More Funding Highlights to Close 1Q 2025 - MedCity News","headline":"An AI Biotech Hauls In $600M, Plus More Funding Highlights to Close 1Q 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOUUczYW1EcEc1S1BpYmFFU1B4bnBRbE40SmpFR1pfU2hHNzFxZ1Z2Z25NelJYaGpyUGV1aGVXMVZ0WUh3NUNfSXZyNXVaTEhPTlpqVWx5SDBkdXlOOGEyQ2NQWjZBekRiUmpaWHEzZ21SbVNfM3V0SjlXa0h2ZElwdERRakFLT1AzMTl3eUhkWkE?oc=5","date":"2025-03-27","type":"pipeline","source":"The Pharma Letter","summary":"$68 million for Epicrispr’s development of FSHD candidate - The Pharma Letter","headline":"$68 million for Epicrispr’s development of FSHD candidate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPY3pvcG53d3lTWlhDOTYzaE44d0VPOHViZ1lpYlRLTUhBeDBGLWpmS0N4WUR3VW1UVDBpVmQwNWtFWDNzbWtpUm95TnIyS1RueTFvdUx6ZkRCR2ZhSkNfby1PdXdBSGlCWnpUTzY5YmZfanhKbno3RWZVRnA1bHlldkZIVU04WmprbV9mbmhkRFgyS2JPZlJLcmN2UQ?oc=5","date":"2025-03-26","type":"pipeline","source":"BioPharma Dive","summary":"Epicrispr banks $68M to test epigenetic editing on rare muscle disease - BioPharma Dive","headline":"Epicrispr banks $68M to test epigenetic editing on rare muscle disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOclhSbkJRLUJyWTFlZmFHUzRsZzZtYk5Yak1wRWpZcmp0XzBEdUdGYzdlWUV1UkJwUkhfZVdrVTFXS1NBZ2RwNUN6QUw0TlFoRXI4djhWT2x1d2gzWkxmQ1FqZ3BRM0FFNEdFVUl4cGt2U1BDcFc2REg2S0toR1F0WURlWkxzdEVVcjVGczJ6WEEzYTNZNlVtVGlWQTRnb3hyZEx6RUhVdw?oc=5","date":"2025-02-26","type":"pipeline","source":"BioSpace","summary":"U.S. Biotechnology Market Size to Hit USD 1,794.11 Billion by 203 - BioSpace","headline":"U.S. Biotechnology Market Size to Hit USD 1,794.11 Billion by 203","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPNERoS1liR1ZKTy15T2w3NUdrcEVUWnlyc3A4VHZFcUFTdkp1d3hIbHgxLWx2SEY3VzFseDdxREk0YW1MSktHUlNWMXZ3a1VxOThkdFF4M1h2eC1wMkstZ2Y5NllTV2xZSzM1Qjk0UEVtckVGendZdS05RTBnTjN6VlZvRGtJeHJEcGRUT1dzT0UzdUVmUGRPVw?oc=5","date":"2025-02-07","type":"pipeline","source":"BioCentury","summary":"Science Spotlight: New protein degradation mechanism - BioCentury","headline":"Science Spotlight: New protein degradation mechanism","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE5KYWltUm5DS0RXdklEaGJOdkhEd0kzcU5DNTNsdVhXMkQ2Q0VSaW55OGY5OWxSSHdoTlVsUnVicHNzWE9UM1lJRXhhY09xU3RhMmFQeTZRM2tuZE5jUkM4V2FDQjlQUWMyN1VNalFjbjVZOG45SHdGVTd6a3A?oc=5","date":"2023-08-28","type":"pipeline","source":"Fierce Biotech","summary":"Introducing Fierce Biotech's 2023 Fierce 15 - Fierce Biotech","headline":"Introducing Fierce Biotech's 2023 Fierce 15","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}